Logic Model Two-Page Detailed Examples

Transcription

1 Logic Model Two-Page Detailed Examples

2 Strategy: Community Awareness & Linkage to Care Definition: Programs that provide communities and patients with health-related information on disease prevention and treatment, or improve links between patients and the health care system. Target audience of the activities: The individual patient and/or the patient community. Activities Examples Key Output Measures Planning Planning activities could include workplanning meetings, board meetings, stakeholder/community organization engagement meetings and any report writing related to planning and managing the program. Include any other activities you would categorize as planning/managing the program. Staff time spent planning community awareness programs that aim to improve patient awareness of prevention, diagnosis, treatment and care options. Communication Infrastructure Technology Mobilization Funding Communication activities include mass media campaigns, community meetings, materials development which all have a goal of building community awareness about components of the program and/or disease prevention and treatment. Infrastructure activities include any building construction, building refurbishment, and/or equipment donation that all contribute to improving community awareness and linkage to care. Technology activities include any design/creation of tools (e.g. paper-based or electronic) and/or information systems used to improving community awareness and linkage to care. Audience of the tool is the patient NOT the provider. Mobilization activities include work with community groups to build awareness and/or support structures for patient communities. Funding activities include grants, loans or donations to local/regional organizations/groups by the program to further improving community awareness and linkage to care. Population exposed to said media campaigns, meetings and materials. Population is the target patient population. Buildings/equipment in use where community awareness and patient linkage activities are offered or hosted. Number of tools introduced and in use by the community awareness and patient linkage programs. Number of community groups supported by the program. Support = any financial or in-kind transaction aimed to provide funding, goods or services to facilitate the activities of community groups. Total amount of awards disbursed by the program for specific community awareness and patient linkage to care activities.

3 Strategy: Community Awareness & Linkage to Care INSTRUCTIONS: If you selected this Strategy: For each of the inputs, outputs, outcomes, and impacts select ONLY the s that you plan on collecting/already collect and plan to report into the Access Observatory. Feel free to tick Add Additional Indicator if you collect additional s not list. Once done selecting, go to the Reporting Form Data Indicator Worksheet to complete additional information for each. COMMUNITY AWARENESS & LINKAGE TO CARE: Indicators Inputs Outputs Outcomes Impacts Value of Resources Staff time Staff time spent planning Population exposed Buildings/equipment in use Tools in use Groups supported Knowledge of disease symptoms Knowledge of treatment options Adoption of preventative health behaviors Population health Financial protection Patient satisfaction Funding provided

4 Strategy: Health Service Strengthening Definition: Programs designed to improve the availability, and affordability, and quality of health services. Common activities include planning, training, infrastructure, technology, management, or funding activities. Also included are programs that deliver health services directly to patients. Target audience of the activities: The health care providers and the health system itself. Activities Examples Key Output Measures Planning Planning activities could include workplanning meetings, board meetings, stakeholder/community organization engagement meetings and any report writing related to planning and managing the program. Include any other activities you would categorize as planning/managing the program. Staff time spent planning programs that aim to improve the availability, and affordability, and quality of health services. Training Infrastructure Technology Management Funding Training activities could include development of teaching materials, holding trainings sessions, and provision of mentorship to improve health provider knowledge and quality of care. Infrastructure activities could include any building construction, building refurbishment, and/or equipment donation that all contribute to improving diagnosis, treatment, and retention in care. Technology activities could include any design/creation of tools (e.g. paperbased or electronic) and/or information systems used to improve availability, and affordability, and quality of health services. Audience of the tool can be the patient of the provider. Management activities could include development of any protocols/procedures that aim to improve the health system such as management of service provision, governance and accountability, human resources, and finances. Funding activities could include grants, loans or donations to local/regional organizations/groups by the program to improve the availability, and affordability, and quality of health services. Trainees indicated the number of people who are participants of said trainings. Population is the target provider population. Buildings/equipment in use where health services are offered and patients can receive care. Number of tools introduced and in use in the health system as a result of the program. Number of procedures in use in the health care system that were developed by the program. Total amount of awards disbursed by the program into the health system.

5 Strategy: Health Service Strengthening INSTRUCTIONS: If you selected this Strategy: For each of the inputs, outputs, outcomes, and impacts select ONLY the s that you plan on collecting/already collect and plan to report into the Access Observatory. Feel free to tick Add Additional Indicator if you collect additional s not list. Once done selecting, go to the Reporting Form Data Indicator Worksheet to complete additional information for each. HEALTH SERVICE DELIVERY: Indicators Inputs Outputs Outcomes Impacts Value of Resources Staff time Staff time spent planning # trainees Buildings/equipment in use Tools in use Health provider knowledge Population access to health services Cost/efficiency of health service delivery Population health Household financial risk protection Population satisfaction Procedures in use Funding provided Patients properly diagnosed Patients on appropriate treatment Patients retained in care

6 Strategy: Health Service Delivery Definition: Programs designed to deliver health services directly to patients. Common activities include screening, diagnosis, treatment, and retention Target audience of the activities: The people and/or patients receiving health care services. Activities Examples Key Output Measures Screening Screening activities could include any screening procedures (mammogram, cholesterol measurement, colonoscopy, etc.) delivered directly to a specified population, by the program. Screening activities are often preventive in nature and aim to look for diseases or conditions prior to symptoms developing. Population screened for diagnosis as a result of the screening test or procedure being provided by the program. Diagnosis Treatment Retention Diagnosis activities could include any diagnostic procedures and decisions delivered by a clinician (MRI, CAT scan, biopsy, etc.), directly to patients who already present with symptoms of a disease or condition. Treatment activities could include any course of treatment (chemotherapy, ART, etc.) delivered directly to patients, by the program. Retention activities could include any activity aimed at improving patient retention in care (regularly scheduled follow-ups, SMS reminders, etc.) that is delivered directly to the patient, by the program. Patients properly diagnosed as a result of the diagnostic test being provided by the program. Patients on appropriate treatment as a result of the course of treatment being provided by the program. Patients retained in care as a result of the retention activities being provided by the program.

7 Strategy: Health Service Delivery INSTRUCTIONS: If you selected this Strategy: For each of the inputs, outputs, outcomes, and impacts select ONLY the s that you plan on collecting/already collect and plan to report into the Access Observatory. Feel free to tick Add Additional Indicator if you collect additional s not list. Once done selecting, go to the Reporting Form Data Indicator Worksheet to complete additional information for each. HEALTH SERVICE DELIVERY: Indicators Inputs Outputs Outcomes Impacts Value of Resources Staff time Population screened Patients properly diagnoses Patients on appropriate treatment Patients retained in care Add additional Patients on appropriate treatment Time from first symptom to diagnosis Cost/efficiency of treatment services Adherence to treatment Patients properly diagnosed Patients retained in care Population health Household financial risk protection Population satisfaction Add additional Time from diagnosis to treatment initiation Time from treatment initiation to lost-to-followup Add additional

8 Strategy: Supply Chain Definition: Programs designed to improve medicine supply chains, and thus improve availability and lower costs. Common activities include planning, training, infrastructure, technology, management, or funding activities. Target audience of the activities: The staff who work operate and manage the supply chain at various levels (i.e. facility, regional, national, global) depending on the program scope. Activities Examples Key output measure Planning Planning activities could include workplanning meetings, board meetings, and any report writing related to planning and managing the supply chain (specifically as is relevant for the access program ). Include any other activities you would categorize as planning/managing the program. Staff time spent planning programs that aim to improve the functioning of the supply chain. Training Infrastructure Technology Management Funding Training activities could include development of teaching materials, holding trainings sessions, and provision of mentorship to improve staff knowledge of supply chain procedures. Infrastructure activities could include any building construction, building refurbishment, and/or equipment donation that all contribute to improving the supply chain (e.g. warehouses, trucks, MHE, racking, shelving, etc.) Technology activities could include any design/creation of tools (e.g. paperbased or electronic) and/or information systems used to improve medicine supply chains, to improve data quality and availability (e.g. a Logistics Management Information System or warehouse management system or facility inventory system) Management activities could include development of any protocols/procedures that aim to improve the medicine supply chain such as management of service provision, governance and accountability, human resources, and finances. Funding activities could include grants, loans or donations to local/regional organizations/groups by the program to improve medicine supply chains. Number of trainees exposed to said trainings. Population is the target is supply chain staff. Buildings/equipment in use that specifically support supply chain operations. Number of tools introduced and in use in the supply chain as a result of the program. Number of procedures in use that were developed by the program and support the supply chain. Total amount of awards disbursed by the program that directly support the supply chain.

9 Strategy: Supply Chain INSTRUCTIONS: If you selected this Strategy: For each of the inputs, outputs, outcomes, and impacts select ONLY the s that you plan on collecting/already collect and plan to report into the Access Observatory. Feel free to tick Add Additional Indicator if you collect additional s not list. Once done selecting, go to the Reporting Form Data Indicator Worksheet to complete additional information for each. SUPPLY CHAIN: Indicators Inputs Outputs Outcomes Impacts Value of Resources Staff time Staff time spent planning # trainees Buildings/equipment in use Tools in use Procedures in use Continuity in Supply Chain Quality of supply chain data Availability of medicines at outlets Volume of expired medicines Population health Household financial risk protection Population satisfaction Funding provided On-time medicine stock delivery

10 Strategy: Financing Definition: Programs designed to improve health financing systems, reduce catastrophic health expenditure, and increase patient access to insurance. Common activities include planning, training, infrastructure, technology, management or funding activities. Target audience of the activities: The staff and leadership who work in the health system (public or private), including insurance companies and government policy makers. Activities Examples Key output measure Planning Planning activities could include workplanning meetings, board meetings, stakeholder/community organization engagement meetings and any report writing related to planning and managing the program. Include any other activities you would categorize as planning/managing the program. Staff time spent planning programs that aim to improve range of services including in a financing scheme, to improve patient access to the schemes, and to reduce costs of administering these schemes. Training Infrastructure Technology Training activities could include development of teaching materials, holding trainings sessions, Infrastructure activities could include any building construction, building refurbishment, and/or equipment donation that all financing operations. Technology activities could include any design/creation of tools (e.g. paper-based or electronic) and/or information systems used to improve efficiency of operating the financing scheme. Number of trainees exposed to said trainings. Population is the target provider population. Buildings/equipment in use where financing operations or activities occur (i.e. offices) Number of tools introduced and in use in the health system supporting financing activities as a result of the program. Management Funding Management activities could include development of any protocols/procedures that aim to improve the operation and access of the financing scheme, such as client management, governance and accountability, human resources, and finances. Funding activities could include advocacy for additional funding put forth by government or private entities to operate the financing scheme. Number of procedures in use that were developed by the program and support the financing scheme. Total amount of funding allocated to a financing scheme.

11 Strategy: Financing INSTRUCTIONS: If you selected this Strategy: For each of the inputs, outputs, outcomes, and impacts select ONLY the s that you plan on collecting/already collect and plan to report into the Access Observatory. Feel free to tick Add Additional Indicator if you collect additional s not list. Once done selecting, go to the Reporting Form Data Indicator Worksheet to complete additional information for each. FINANCING: Indicators Inputs Outputs Outcomes Impacts Value of Resources Staff time Staff time spent planning # trainees Buildings/equipment in use Tools in use Procedures in use Funding provided Treatments and services covered by financing scheme Population access to financing scheme Patients properly diagnosed Patients on appropriate treatment Patients retained in care Population enrolled in financing scheme Household out-of-pocket expenditures: Total health Household out-of-pocket expenditures: medicines/treatment Adoption of preventive behaviors Population health Household financial risk protection Population satisfaction

12 Strategy: Regulation & Legislation Definition: Programs designed to improve and harmonize pharmaceutical regulatory systems. Common activities include planning, training, infrastructure, technology, management or funding activities. Target audience of the activities: National and regional level policy-makers as well as staff of national or regional Medicines Regulatory Agencies (MRA). Activities Examples Key output measure Planning Planning activities could include workplanning meetings, board meetings, meetings and any report writing related to planning and managing the program. Include any other activities you would categorize as planning/managing the program. Staff time spent planning programs that aim to improve the quality of medicines via improving pharmaceutical regulatory policies, procedures, and systems. Training Training activities could include development of teaching materials, holding trainings sessions, and provision of mentorship to MRA staff. Number of trainees exposed to said trainings. Infrastructure Technology Management Funding Infrastructure activities could include any building construction, building refurbishment, and/or equipment donation that all contribute to improving medicines regulatory activities (e.g. laboratories, offices, etc.) Technology activities could include any design/creation of tools (e.g. paperbased or electronic) and/or information systems used to improve medicine quality and/or medicine regulatory procedures. Management activities could include development of any protocols/procedures that aim to improve the MRA as an organization such as management of activities, governance and accountability, human resources, and finances. Funding activities could include grants, loans or donations to local/regional organizations/groups by the program to improve medicine quality and regulatory processes. Buildings/equipment in use where medicines regulatory activities take place. Number of tools introduced and in use in the pharmaceutical regulatory system as a result of the program. Number of procedures in use that were developed by the program and support the pharmaceutical regulatory system. Total amount of awards disbursed by the program that directly support the medicines regulatory space.

13 Strategy: Regulation & Legislation INSTRUCTIONS: If you selected this Strategy: For each of the inputs, outputs, outcomes, and impacts select ONLY the s that you plan on collecting/already collect and plan to report into the Access Observatory. Feel free to tick Add Additional Indicator if you collect additional s not list. Once done selecting, go to the Reporting Form Data Indicator Worksheet to complete additional information for each. REGULATION & LEGISLATION: Indicators Inputs Outputs Outcomes Impacts Value of Resources Staff time spent planning Harmonization in regulatory practices Population health Staff time # trainees Buildings/equipment in use Tools in use Registration process duration Meeting target MRA performance standards Medicines registered and withdrawn Household financial risk protection Population satisfaction Procedures in use Quality of registered medicines Funding provided Safety of registered medicines Transparency in regulatory process

14 Strategy: Manufacturing Definition: Programs designed to build capacity for medicine production with the aim of reducing cost and improving quality. Common activities include planning, training, infrastructure, technology, management, or funding activities. Target audience of the activities: The staff at companies manufacturing medicines. Activities Examples Key output measure Planning Planning activities could include workplanning meetings, board meetings, and any report writing related to planning and managing the program that focuses on expanding manufacturing. Include any other activities you would categorize as planning/managing the program. Staff time spent planning programs that aim to improve volume and quality of medicines manufactured. Training Infrastructure Technology Management Funding Training activities could include development of teaching materials, holding trainings sessions, and provision of mentorship to improve manufacturing capability. Infrastructure activities could include any building construction, building refurbishment, and/or equipment donation that all contribute to improving medicines manufacturing capability. Technology activities could include any design/creation of tools (e.g. paperbased or electronic) and/or information systems used to improve medicine production to improve availability and lower costs. Management activities could include development of any protocols/procedures that aim to improve the medicine manufacturing capacity such as management of production, governance and accountability, human resources, and finances. Funding activities could include grants, loans or donations to local/regional organizations/groups by the program to improve/expand medicines manufacturing. Number of trainees exposed to said trainings. Buildings/equipment in use where medicines are manufactured or assembled. Number of tools introduced and in use in the health system as a result of the program. Number of procedures in use that were developed by the program and support the medicines manufacturing in a country. Total amount of awards disbursed by the program that directly support the improved and/or expanded medicine manufacturing.

15 Strategy: Manufacturing INSTRUCTIONS: If you selected this Strategy: For each of the inputs, outputs, outcomes, and impacts select ONLY the s that you plan on collecting/already collect and plan to report into the Access Observatory. Feel free to tick Add Additional Indicator if you collect additional s not list. Once done selecting, go to the Reporting Form Data Indicator Worksheet to complete additional information for each. MANUFACTURING: Indicators Inputs Outputs Outcomes Impacts Value of Resources Staff time Staff time spent planning # trainees Buildings/equipment in use Tools in use Procedures in use Funding provided Medicines approved and reaching market Volume of medicines sold Quality of medicines Medicine production costs Price of medicines at outlets Availability of medicines at outlets Patients on appropriate treatment Population health Household financial risk protection Population satisfaction

16 Strategy: Product Development Research Definition: Programs designed to support product (e.g. products, devices, etc.) development research through planning, training, infrastructure, technology, or funding activities. Relevant research areas include bench science, pre-clinical and clinical trials, and post-marketing monitoring. Target audience of the activities: Research staff and research institutions that focus on product development. Activities Examples Key output measure Planning Planning activities could include workplanning meetings, board meetings, organization engagement meetings and any report writing related to planning and managing the program. Include any other activities you would categorize as planning/managing the product development program. Staff time spent planning either/or both/and (1) programs that aim to increase researcher knowledge; (2) initiatives to build institutional capacity and linkages around product development. Training Infrastructure Technology Management Funding Training activities could include development of teaching materials, holding trainings sessions, and provision of mentorship to improve researcher knowledge and institutional ability to develop medicines. Infrastructure activities could include any building construction, building refurbishment, and/or equipment donation that all contribute to improving product development capability. Technology activities could include any design/creation of tools (e.g. paperbased or electronic) and/or information systems used to improve product development processes. Management activities could include development of any protocols/procedures that aim to improve product development such as pipeline management, laboratory processes, governance and accountability, human resources, and finances. Funding activities could include grants, loans or donations to local/regional organizations/research institutions by the program or external funders to improve product development. Number of trainees exposed to said trainings. Target population is most likely research staff or other staff of product development organization. Buildings/equipment in use where product development research occurs. Number of tools introduced and in use in the product development institution as a result of the program. Number of procedures in use that were developed by the program and support the product development. Total amount of awards disbursed by the program that directly support product development.

17 Strategy: Product Development Research INSTRUCTIONS: If you selected this Strategy: For each of the inputs, outputs, outcomes, and impacts select ONLY the s that you plan on collecting/already collect and plan to report into the Access Observatory. Feel free to tick Add Additional Indicator if you collect additional s not list. Once done selecting, go to the Reporting Form Data Indicator Worksheet to complete additional information for each. PRODUCT DEVELOPMENT RESEARCH: Indicators Inputs Outputs Outcomes Impacts Value of Resources Staff time spent planning Researcher knowledge Population health Staff time # trainees Buildings/equipment in use Tools in use Researcher/institutions affiliated Amount of local and international funding from external funders Household financial risk protection Population satisfaction Procedures in use Funding provided New evidence on product safety, efficacy, and effectiveness New medicines/products

18 Strategy: Licensing Agreement Definition: Programs designed to support local manufacture, importation, sale or use of medicines through legally binding relationships including voluntary agreements and technology sharing. Target audience of the activities: Manufacturers and patent pools are the target audience including publicly owned manufacturers Activities Examples Key output measure Voluntary Agreement Patent registration Technology Voluntary agreements for generic manufacture, importation of APIs, finished dosage forms; licenses granted to patent pools; licenses granted to manufacturers. Examples include: Low royalty rate (e.g., 4-5%) on licensee sales adjusted for gross domestic product (GDP) of the country, so that in the poorest target countries, a very low or no royalty rate would apply. White knight clause to provide for the establishment of a benefit flowing to the local community, e.g., some portion of royalty stream (if any) might go into a community trust fund. Non-assert clause: Licensor will not, before or after the date of agreement, assert any patent infringement suit against any entity that sells or offers to sell the patented product to the public sector in the target country(ies). Companies may share proprietary technical manufacturing knowledge with other companies to expand production capability of API or finished dosage forms; Companies may also share market authorization research data to facilitate more rapid registration in various countries. Licenses granted = number of voluntary licenses granted by the patent holder. Patents not enforced = number of countries where the patent is subject to one or more of the following conditions: The patent has not been filed; the patent has not been filed and not yet issued; The patent has been issued but the patent owner agrees not to assert it against third parties; the patent has expired. Companies benefiting from technology sharing = the number of companies benefiting of the shared technology related to the program activity. Benefitting includes the use or sales of the technology.

19 Strategy: Licensing Agreement INSTRUCTIONS: If you selected this Strategy: For each of the inputs, outputs, outcomes, and impacts select ONLY the s that you plan on collecting/already collect and plan to report into the Access Observatory. Feel free to tick Add Additional Indicator if you collect additional s not list. Once done selecting, go to the Reporting Form Data Indicator Worksheet to complete additional information for each. LICENSING AGREEMENT: Indicators Inputs Outputs Outcomes Impacts Value of Resources Staff time Licenses granted Patents not enforced Companies benefiting from technology sharing Medicines approved and reaching market Volume of medicines sold Quality of medicines Medicines production costs Price of medicines at outlets Availability of medicines at outlets Patients on appropriate treatment Population health Household financial risk protection Population satisfaction

20 Strategy: Price Scheme Definition: Programs designed to increase the affordability of medicines for individuals and healthcare systems through a reduction in the price via subsidies or other means (excluding donations). Target audience of the activities: The patients receiving the medicines and the providers in the health system prescribing or supplying those medicines; potential other target audiences include national financing staff and supply chain staff. Activities Examples Key output measure Pricing Pricing activities could include a variety of programmatic options to reduce the price of the medicine: Volume of medicines sold with volume expressed in defined daily dose (DDDs) of each product affected by the pricing scheme sold in a defined Differential pricing- different prices for different markets and/or different prices for patients of different income means period of time. Subsidies- Providing discounts to patients based on defined criteria Vouchers- Providing a coupon for a defined group of patients to redeem medicines at a specific price. Bundling- Buy-one-get-one-free; etc. Delivery Delivery activities include direct distribution of medicines or healthcare products to target patient audience. Number of patients reached who receive the medicine or healthcare product as a result of the price scheme. Communication Promotion activities may include any public messaging that to build awareness of specific disease symptoms and value of treatment as well as the availability of treatment. This is not specific promotion of the medicine or company itself. Population exposed to promotional activities informing them about the pricing scheme; this may include patients, general community, and providers in the healthcare system.

21 Strategy: Price Scheme INSTRUCTIONS: If you selected this Strategy: For each of the inputs, outputs, outcomes, and impacts select ONLY the s that you plan on collecting/already collect and plan to report into the Access Observatory. Feel free to tick Add Additional Indicator if you collect additional s not list. Once done selecting, go to the Reporting Form Data Indicator Worksheet to complete additional information for each. PRICE SCHEME: Indicators Inputs Outputs Outcomes Impacts Value of Resources Staff time Volume of medicines sold Number of patients reached Population exposed to communication activities Price of medicines at outlets Availability of medicines at outlets Provider awareness of program Patient awareness of program Household out-ofpocket expenditures: Total health Household out-ofpocket expenditures: medicines/treatment Patients on appropriate treatment Patients receiving program medicines Population health Household financial risk protection Population satisfaction

22 Strategy: Medicine Donation Definition: Programs designed to increase the availability and/or affordability of medicines through direct donation of medicines, and other healthcare products, to countries or health institutions or nongovernmental organizations. Does not include compassionate access programs. Target audience of the activities: The individual patient and/or the patient community. Activities Examples Key Output Measure Donation Donation activities include direct donation of medicines or healthcare products to countries, health institutions, non-governmental organizations, or directly to health care providers. Value of the medicine donated indicates the financial value of the medicines donated to the intended recipient measured in terms of the international reference price. Volume of the medicines donated is expressed in Defined Daily Doses of each product donated during a defined period of time. Delivery Delivery activities include direct donation of medicines or healthcare products to target patient audience. Number of patients reached who receive the medicine or healthcare product as a result of the donation. Communication Promotion activities may include any public messaging that to build awareness of specific disease symptoms and value of treatment as well as the availability of treatment. This is not specific promotion of the medicine or company itself. Population exposed to promotional activities; this may include patients, general community, and providers in the healthcare system.

23 Strategy: Medicine Donation INSTRUCTIONS: If you selected this Strategy: For each of the inputs, outputs, outcomes, and impacts select ONLY the s that you plan on collecting/already collect and plan to report into the Access Observatory. Feel free to tick Add Additional Indicator if you collect additional s not list. Once done selecting, go to the Reporting Form Data Indicator Worksheet to complete additional information for each. MEDICINE DONATION: Indicators Inputs Outputs Outcomes Impacts Value of Resources Staff time Volume of medicines donated Value of medicines donated Number of patients receiving the donated products Price of medicines at outlets Availability of medicines at outlets Provider awareness of program Patient awareness of program Household out-of-pocket expenditure: total health Population health Household financial risk protection Population satisfaction Population exposed to communication activities Household out-of-pocket expenditure: medicine Patients on appropriate treatment Patients receiving program medicines